Background: Emerging data suggest that C-reactive protein (CRP), a marker of inflammation, is associated with functional properties of arteries. We investigated the relationship of CRP to measures of arterial wave reflection and stiffness (aortic augmentation index [AIX], carotidfemoral pulse wave velocity [PWV], and pulse pressure) in asymptomatic individuals from the community.
C
-reactive protein (CRP), a marker of systemic inflammation, is associated with increased risk of coronary heart disease (CHD). 1 Whether CRP is a risk factor or a risk marker of vascular disease remains a subject of ongoing debate. Several studies have demonstrated that CRP has atherogenic properties in vitro but less is known about the relationship of CRP with functional properties of the arterial wall. Increased levels of CRP have been shown to be associated with endothelial dysfunction 2 and with increased pulse pressure, a surrogate of large arterial stiffness. 3 Furthermore, in a crosssectional study, CRP levels were noted to be higher in subjects with hypertension 4 and increased baseline CRP levels were associated with future development of hypertension in healthy women 5 and men. 6 Noninvasive measures of arterial function include aortic augmentation index (AIX), a marker of the reflective properties of the arterial bed, 7 aortic pulse wave velocity (PWV), a measure of aortic stiffness, and systemic arterial pulse pressure, which is determined in part by arterial wave reflection as well as arterial stiffness. 7 Recent studies of the relationship of CRP with measures of arterial wave reflection and stiffness have provided differing results. Yasmin et al 8 found CRP to be related to carotid-femoral PWV but not to AIX, in patients drawn from general practitioner lists in the United Kingdom who were free of cardiovascular and renal disease and who did not take any medications. On the other hand, Kampus and colleagues 9 found CRP levels to be independently and significantly associated with AIX in asymptomatic individuals attending a university hospital. The two studies did not draw subjects from the community and excluded subjects with diabetes and hypertension. Amar et al, 10 in a populationbased sample, found that CRP was related to pulse pressure even after adjustment for PWV. However, a measure of wave reflection such as AIX was not studied.
In the present study we investigated the association of CRP levels with AIX, PWV, and pulse pressure in asymptomatic subjects drawn from the community and without prior history of CHD or stroke.
Methods

Study Population
Subjects were participants in the National Institutes of Health-funded Functional Arterial Changes in Atherogenesis Study, which is examining the relationship of measures of arterial function to subclinical coronary atherosclerosis and cardiovascular risk factors in non-Hispanic white subjects in the community-based Epidemiology of Coronary Artery Calcification (ECAC) study. 11 The ECAC study is an ongoing study of the pathogenesis of coronary artery calcification in Rochester, Minnesota.
11 Participants are not physician or self-referred and were recruited from the community-based Rochester Family Heart Study. 12, 13 Participants were recruited independent of risk factor and disease status except they did not have a history of previous bypass surgery, angioplasty, or coronary surgery. 14 Between September 2002 and December 2003, 224 subjects from the ECAC study had completed the Functional Arterial Changes in Atherogenesis Study protocol. Study protocols were approved by the Mayo Clinic and University of Michigan Institutional Review Boards and participants gave written informed consent. Ten subjects who reported a history of previous myocardial infarction or stroke were excluded from the present analysis. The study group included 114 men and 100 women.
Weight was measured by an electronic balance, height by a stadiometer, and body mass index (BMI) was calculated in units of kilograms per meters squared. Resting blood pressure (BP) levels were measured in the right arm with a random-zero sphygmomanometer (Hawksley and Sons, West Sussex, UK) and pulse pressure and mean arterial pressure were calculated. Blood samples were obtained by venipuncture after an overnight fast. Standard enzymatic methods were used to measure total cholesterol, HDL-cholesterol, triglycerides and plasma glucose. Plasma CRP levels were measured by a highly sensitive immunoturbidimetric assay. 15 Information about medication use including aspirin, antihypertensive medications, statins, oral hypoglycemic agents, and insulin, was obtained at the time of the study. Type 2 diabetes was considered present if a subject was being treated with insulin or oral agents or had a fasting glucose level Ͼ125 mg/dL. History of smoking was defined as having smoked more than 100 cigarettes in the past. The diagnosis of hypertension was determined based on BP levels measured at the study visit (systolic BP Ն140 mm Hg or diastolic BP Ն90 mm Hg) or report of a prior diagnosis of hypertension and current treatment with antihypertensive medications.
Aortic Augmentation Index and Pulse Wave Velocity
Measurements of AIX and PWV were performed noninvasively with the SphygmoCor system (AtCor Medical, Sydney, Australia) after an overnight fast and 24 h off of any antihypertensive medications. Subjects were asked to omit caffeine beverages, smoking, and alcohol for at least 12 h before the assessment. An ascending aortic pressure waveform was derived from the radial artery waveforms recorded at the wrist, using applanation tonometry with a high-fidelity micromanometer (Millar Instruments, Houston, TX) and a previously validated generalized transfer function. 16, 17 The AIX was calculated as the difference between the first and second systolic peaks of the ascending aortic waveform expressed as a percentage of the central pulse pressure (the difference between central systolic and diastolic pressure). A single technician obtained the measurements in Ͼ90% of the subjects. In 10 subjects the within-subject standard deviation of AIX measured using this method was 3.7 (compared to the study sample standard deviation of 10.8).
The carotid-femoral aortic pulse wave velocity was also determined using the SphygmoCor system by sequentially recording electrocardiographic-gated carotid and femoral artery waveforms by applanation tonometry. 18 Distances from the carotid sampling site to the manubrium sternum and from the manubrium sternum to the femoral artery were measured as straight lines between the points on the body surface using a tape measure. The time (t) between the onset of femoral and carotid waveforms was determined as the mean from 10 consecutive cardiac cycles. The PWV was calculated from the distance between measurement points (D) and the measured time delay (t) as follows: PWV ϭ D/t (m/sec), where D is distance in meters and t is the time interval in seconds. In 10 subjects the within-subject standard deviation of PWV measured using this method was 0.66 m/sec (compared to the study sample standard deviation of 2.9 m/sec).
Statistical Methods
Descriptive statistics are given as median and standard deviation (as well as median and quartiles) or frequency and percent. The CRP values were log-transformed to reduce skewness. Pairwise associations among AIX, PWV, and pulse pressure were assessed by Pearson partial correlation coefficients before and after adjustment for heart rate and height. Heart rate and height are known to be associated with measures of arterial stiffness and wave reflection. 19, 20 Using linear regression we tested the association of measures of arterial wave reflection and stiffness (AIX, PWV, and pulse pressure) one at a time with log CRP, heart rate, height, and CHD risk factors (age, sex, BMI, mean arterial pressure, total cholesterol, HDL-cholesterol, diabetes, hypertension, and history of smoking). We then constructed separate backward elimination multiple linear regression models to determine whether log CRP was independently associated with the AIX, PWV, and pulse pressure after adjustment for heart rate, height, and the CHD risk factors enumerated previously. Statistical significance was inferred at P values Ͻ .05. A significance level of P Ͻ .10 was used as a requirement for a predictor variable to remain in the backward elimination models. Statistical analyses were performed with SAS v 8.2 (SAS Institute, Cary, NC).
Results
The mean age of subjects was 59.6 years, 53% of the subjects were men, 49% were hypertensive, and 9% had type 2 diabetes (Table 1) . Ninety-four subjects (44%) were on antihypertensive medications. Of these 94 subjects, 53 were on more than one antihypertensive medication; 53 were on diuretics, 47 on renin-angiotensin antagonists (38 on an angiotensin-converting enzyme inhibitor, 8 taking an angiotensin receptor blocker, and 1 taking both), 39 on ␤-blockers, 22 on calcium-channel blockers, and 6 on other antihypertensive medications.
The AIX, PWV, and pulse pressure were significantly correlated before and after adjustment for heart rate and height (Table 2) .
Log CRP was significantly correlated with AIX, PWV, and pulse pressure (Fig. 1) . In linear regression analyses, individual variables positively associated with AIX were log CRP, age, mean arterial pressure, HDL-cholesterol, hypertension, and hypertension medication use (Table 3) . Greater height and male sex were associated with lower AIX (Table 3) . Variables positively associated with increased aortic PWV included heart rate, log CRP, age, mean arterial pressure, hypertension, hypertension medication use, aspirin use, and diabetes. Height was negatively associated with PWV. Variables positively related to pulse pressure included log CRP, age, BMI, mean arterial pressure, hypertension, hypertension medication use, statin use, aspirin use, and diabetes. Height and male sex were negatively associated with pulse pressure. In a backward elimination multiple regression model to predict AIX, log CRP was significantly and positively associated with AIX after adjustment for CHD risk factors (P ϭ .038; Table 4 ). In this regression model, greater age, log CRP, mean arterial pressure, and history of smoking were each significantly associated with greater AIX, whereas greater height, heart rate, and BMI were each associated with a lower AIX.
In a backward elimination multiple regression model to predict PWV, log CRP remained associated with PWV, although the inclusion of CHD risk factors in the model resulted in attenuation of the association (P ϭ .054; Table  4 ). Greater heart rate, age, log CRP, and mean arterial pressure were each associated with a higher PWV, and greater BMI, total cholesterol, and HDL-cholesterol were associated with lower PWV.
In the backward elimination multiple regression model for pulse pressure, log CRP was associated with pulse pressure even after adjustment for CHD risk factors (P ϭ .036, Table 4 ). In this model, greater age, log CRP, mean arterial pressure, hypertension, and diabetes were each associated with a higher pulse pressure and greater height and BMI were associated with a lower pulse pressure (Table 4) .
Discussion
The present study assessed the relationship of CRP, a marker of subclinical inflammation, to measures of arterial wave reflection and stiffness in asymptomatic individuals from the community. We found a statistically significant and independent association of CRP with AIX and pulse pressure, and a borderline significant association with carotid-femoral PWV, even after adjustment for CHD risk factors.
The AIX is a measure of arterial stiffness and wave reflective properties of the arterial bed, the latter in turn being influenced by physical properties, vasomotor tone, Abbreviation as in Tables 1 and 2 . The ␤ coefficients represent the amount of change in the predicted response (AIX, PWV, pulse pressure) for a one standard deviation change in a continuous variable and the presence versus absence difference in the case of a categorical variable. and the number of smaller resistive arteries and branch points. 7, 21, 22 Arterial wave reflectance measures may have implications for CHD risk, as AIX has been found to be associated with the presence and extent of angiographic coronary artery disease in men aged Ͻ60 years 23 and with cardiovascular disease events in patients with renal disease. 22 Our findings are consistent with those from a recent study by Kampus and colleagues, 9 who found CRP levels to be independently and significantly associated with AIX and central (aortic) pulse pressure in 158 asymptomatic individuals (mean age 49.7 years) attending a university hospital in Estonia. However, Yasmin et al 8 did not find CRP to be related to AIX in 457 subjects (mean age 47 years), drawn from general practitioner lists in United Kingdom. Patients with diabetes, hyperlipidemia, and treated hypertension were excluded. Although mean CRP levels were similar (4.0 Ϯ 5.6 mg/L v 4.0 Ϯ 7.0 mg/L in the present study) the mean AIX was lower than in our study (16.1 Ϯ 18.0 v 30.2 Ϯ 10.8 in the present study).
Yasmin et al 8 noted CRP to be significantly and independently related to PWV, whereas we found the association was of borderline significance after adjustment for CHD risk factors. Tomiyama et al 24 found that CRP was associated with brachial-ankle PWV before, but not after adjustment for CHD risk factors in 2668 Japanese men (mean age 43 years). These findings suggest that the relationship of CRP with PWV is partly confounded by conventional risk factors.
The association of CRP to pulse pressure has been consistently noted in other studies. Abramson and Vaccarino 3 found that CRP levels were associated with increased pulse pressure among apparently healthy adults, independent of systolic and diastolic BP. In the studies of both Yasmin et al 8 and Kampus et al, 9 CRP was significantly and independently associated with pulse pressure. Altered arterial wave reflection and large artery stiffness are determinants of pulse pressure 7 and the significant association of CRP with both these measures in the present study may partly explain the association of CRP and pulse pressure.
Because the present study was based on cross-sectional data we can only speculate on the pathophysiologic mechanisms that underlie the association between CRP and measures of arterial stiffness and wave reflection. Subclinical inflammation, by causing endothelial dysfunction and structural arterial changes, may lead to changes in the pulse wave reflectance property of the arterial bed. Recently, AIX and PWV have been found to be elevated in patients with active arteritis compared with controls, suggesting that arterial inflammation may affect arterial wave reflection and large artery stiffness. 25 The AIX is elevated in patients with systemic inflammatory diseases such as rheumatoid arthritis 26 and elevated AIX and PWV have been noted in patients with systemic vasculitis compared to controls. 25 In the latter study, CRP levels were positively correlated with AIX and PWV. 25 Alternatively, changes in the arterial physiology, as manifest in altered wave reflection, may precede elevation in CRP levels. Increased pulse pressure has been found to be associated with generation of proinflammatory reactive oxygen species 27, 28 and altered flow patterns in arteries have been found to increase the expression of adhesion molecules. 29 We noted inverse relationships of AIX, PWV, and pulse pressure with BMI. The AIX has been observed to be inversely related to BMI in two previous studies. 30, 31 The pathophysiologic basis for this inverse association is unclear. The relation of CRP, age, and mean arterial pressure was consistent across AIX, PWV, and pulse pressure Abbreviation as in Table 1 . Models were built starting with all the variables shown and additionally male sex, hypertensive medication use, statin use, and aspirin use. Variables were removed until all remaining variables were significant at P Յ .10. The ␤ coefficients represent the amount of change in the predicted response (AIX, PWV, pulse pressure) for a one standard deviation change in a continuous variable and the presence versus absence difference in the case of a categorical variable.
but smoking, HDL-cholesterol, and diabetes were associated with these measures in a differential manner. We found history of smoking to be significantly associated with increased AIX but not with PWV and pulse pressure. The increased AIX in smokers has been previously noted in another study. 32 HDL-cholesterol was inversely associated with PWV. Type 2 diabetes was associated with increased pulse pressure, but was not significantly associated with AIX or pulse pressure.
The strength of the present study is that it is a community-based sample of subjects without history of myocardial infarction or stroke. A potential limitation is that although the subjects were off antihypertensive medications for 24 h, we cannot exclude the possibility of non-BP-related effects of these medications on indices of arterial stiffness and wave reflection. The addition of a variable denoting antihypertensive therapy to the multiple regression models, however, did not alter the inferences. We also did not find any particular antihypertensive drug class to be independently related to the measures of arterial stiffness (data not shown).
In conclusion, CRP, a marker of systemic inflammation, is associated with measures of arterial wave reflection and stiffness in asymptomatic subjects drawn from the community. These findings add to the growing body of evidence linking inflammation to functional alterations of the arterial bed. Further studies are needed to understand the mechanisms underlying this association and the implications for assessment and management of CHD risk. 33 
